Boston Massachusetts | U.S.A.
| Investor Type | Firm |
| Type of Fund | VC |
| Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Oncology • Pharmaceutical (& Medicine) |
| Stages | Early, Seed, Series A, Series B |
| Investing | United States • Canada • Israel • Belgium • Ireland |
| Investment Range | $100,000 - $5,000,000 |
| Investment Sweet Spot | $1,500,000 |
| Assets Under Management | $250,000,000 |
About The Fund
Lightstone Ventures is a venture capital firm specializing in early-stage investments within the healthcare and life sciences sectors. Founded in 2012 and headquartered in Menlo Park, California, the firm targets emergent companies primarily in the biotech, medical devices, therapeutics, and novel bio-pharmaceutical industries. With a committed capital fund of $250 million, they deploy investments ranging from $100,000 to $5,000,000, focusing on early, seed, and Series A through B funding rounds. The firm prides itself on a 'thesis-driven' investment approach, emphasizing the identification and support of disruptive technologies anticipated to transform patient outcomes across focused market sectors. Lightstone Ventures' philosophy extends beyond mere financial backing; they engage actively with portfolio companies, contributing nearly 100 years of collective operational expertise, strategically guiding founders from inception through commercialization. Their investment team has been instrumental in notable life science exits, reflected in a track record that spans initial public offerings and acquisitions, showcasing success stories in biotech and medtech. In the biotech domain, Lightstone Ventures concentrates on innovative drug development in multiple disease areas, including CNS disorders, immunology, oncology, and ophthalmology. Regarding medtech, they are intrigued by the convergence of technology, medicine, and consumer health, focusing on personal medicines, therapeutics, and analytics platforms revolutionizing medical technology across various diseases. The firm maintains a global presence, capitalizing on an international footprint to leverage strategic and financial funding sources outside the U.S., as well as unique development and commercialization strategies. Collaboration with founders is key to their ethos; they seek visionary entrepreneurs dedicated to creating industry-first or leading products, and they help assemble adept management teams to materialize those visions. Demonstrating the breadth of their portfolio diversity, Lightstone Ventures features numerous companies spanning biopharmaceuticals, active exits & IPOs, medtech, and therapeutics, each advancing medical science and patient care.
Lightstone Ventures's investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
